Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Debt to Equity (2019 - 2025)

Historic Debt to Equity for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $0.62.

  • Pulmonx's Debt to Equity rose 5601.02% to $0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.62, marking a year-over-year increase of 5601.02%. This contributed to the annual value of $0.43 for FY2024, which is 3763.75% up from last year.
  • As of Q3 2025, Pulmonx's Debt to Equity stood at $0.62, which was up 5601.02% from $0.54 recorded in Q2 2025.
  • Pulmonx's Debt to Equity's 5-year high stood at $0.62 during Q3 2025, with a 5-year trough of $0.0 in Q4 2021.
  • Moreover, its 5-year median value for Debt to Equity was $0.28 (2023), whereas its average is $0.25.
  • Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 4397.84% in 2021, then soared by 795079.43% in 2022.
  • Pulmonx's Debt to Equity (Quarter) stood at $0.0 in 2021, then surged by 7950.79% to $0.11 in 2022, then surged by 179.84% to $0.31 in 2023, then skyrocketed by 37.64% to $0.43 in 2024, then skyrocketed by 42.75% to $0.62 in 2025.
  • Its last three reported values are $0.62 in Q3 2025, $0.54 for Q2 2025, and $0.48 during Q1 2025.